Abnormal concentrations of apoA1 and apoB are associated with a higher risk of chronic conditions, such as T2D (Siegel et al., 1996), CHD (Sniderman et al., 2019), and stroke (Shilpasree et al., 2013). The gene discussed is APOB; the disease is coronary artery disorder.